Roivant Sciences (ROIV) CAO uses 3,582 shares to cover RSU tax bill

Rhea-AI Filing Summary

Roivant Sciences Ltd. Chief Accounting Officer Jennifer Humes reported a routine tax-related share disposition. On this Form 4, 3,582 common shares were surrendered at a value of $31.43 per share to cover tax withholding tied to the vesting of previously granted RSUs. After this net settlement, she directly holds 109,782 common shares, indicating the transaction reflects compensation and tax obligations rather than an open-market sale.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Humes Jennifer

Role Chief Accounting Officer

Type	Security	Shares	Price	Value
Tax Withholding	Common Shares	3,582	$31.43	$113K

Holdings After Transaction: Common Shares — 109,782 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Shares surrendered for taxes: 3,582 shares Share value for withholding: $31.43 per share Shares held after transaction: 109,782 shares +1 more

4 metrics

Shares surrendered for taxes 3,582 shares Tax-withholding disposition of common shares

Share value for withholding $31.43 per share Value used for tax-withholding settlement

Shares held after transaction 109,782 shares Direct common share ownership after Form 4 event

Tax-withholding transactions 1 transaction Single F-code tax-withholding event reported

Key Terms

RSUs, net settlement, tax withholding obligations, vesting and settlement, +1 more

5 terms

RSUs financial

"Represents the "net settlement" by the Issuer of RSUs previously granted"

RSUs, or restricted stock units, are a form of company shares given to employees as part of their compensation. They are typically awarded with certain restrictions, such as a waiting period before they can be fully owned or sold, similar to earning a gift that becomes fully yours over time. For investors, RSUs can impact a company's stock offerings and reflect how much the company relies on stock-based incentives to attract and retain talent.

net settlement financial

"Represents the "net settlement" by the Issuer of RSUs previously granted"

tax withholding obligations financial

"in order to satisfy applicable tax withholding obligations in connection with the vesting"

vesting and settlement financial

"in connection with the vesting and settlement of such RSUs"

Common Shares financial

"security_title": "Common Shares""

Common shares are the basic units of ownership in a company that give holders a claim on profits and a right to vote on key matters, like electing the board. Think of them as membership cards in a club: they let you share in successes and losses, but in a bankruptcy or liquidation they are paid after creditors and preferred shareholders, so their value can swing more and matters for assessing risk and potential return.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Humes Jennifer

(Last) (First) (Middle)

C/O ROIVANT SCIENCES LTD.

7TH FLOOR, 50 BROADWAY

(Street)

LONDON SW1H 0DB

(City) (State) (Zip)

UNITED KINGDOM

(Country)

2. Issuer Name and Ticker or Trading Symbol
Roivant Sciences Ltd. [ ROIV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Accounting Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/20/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares	06/20/2026		F		3,582(1)	D	$31.43	109,782	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents the "net settlement" by the Issuer of RSUs previously granted to the reporting person in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such RSUs.

Remarks:

	/s/ Jo Chen, as Attorney-in-Fact for Jennifer Humes	06/23/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Roivant Sciences (ROIV) report for Jennifer Humes?

Roivant Sciences reported that Chief Accounting Officer Jennifer Humes surrendered 3,582 common shares. The shares were delivered to the company to satisfy tax withholding obligations arising from the vesting and settlement of previously granted restricted stock units, rather than from an open-market sale.

Was the Roivant Sciences (ROIV) Form 4 transaction an open-market sale?

No, the Form 4 transaction was not an open-market sale. The 3,582 shares were withheld by Roivant Sciences in a net settlement to cover tax liabilities triggered when Humes’ restricted stock units vested and settled, a common administrative step for equity compensation.

How many Roivant Sciences (ROIV) shares does Jennifer Humes own after the Form 4 event?

After this tax-withholding transaction, Jennifer Humes directly owns 109,782 Roivant Sciences common shares. This post-transaction holding reported on the Form 4 shows she retains a substantial equity position even after the routine net settlement to satisfy her tax obligations on vested RSUs.

What does transaction code "F" mean in the Roivant Sciences (ROIV) Form 4?

Transaction code "F" on the Roivant Sciences Form 4 indicates shares were disposed of to pay an exercise price or tax liability. Here, 3,582 shares were delivered back to the issuer to satisfy tax withholding tied to the vesting and settlement of restricted stock units.

How large was the Roivant Sciences (ROIV) tax-withholding disposition for Jennifer Humes?

The tax-withholding disposition for Jennifer Humes involved 3,582 common shares valued at $31.43 per share. This net settlement satisfied her applicable tax withholding obligations connected to RSUs vesting, and it did not represent a discretionary buy or sell decision in the open market.